1. Home
  2. OMH vs GTBP Comparison

OMH vs GTBP Comparison

Compare OMH & GTBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ohmyhome Limited

OMH

Ohmyhome Limited

N/A

Current Price

$2.42

Market Cap

3.2M

Sector

Finance

ML Signal

N/A

Logo GT Biopharma Inc.

GTBP

GT Biopharma Inc.

N/A

Current Price

$7.04

Market Cap

13.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OMH
GTBP
Founded
2015
1965
Country
Singapore
United States
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2M
13.0M
IPO Year
2022
2016

Fundamental Metrics

Financial Performance
Metric
OMH
GTBP
Price
$2.42
$7.04
Analyst Decision
Hold
Analyst Count
1
0
Target Price
N/A
N/A
AVG Volume (30 Days)
27.5M
350.3K
Earning Date
05-12-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
3.75
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$28.40
N/A
Revenue Next Year
$23.07
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.06
$0.22
52 Week High
$3.75
$8.82

Technical Indicators

Market Signals
Indicator
OMH
GTBP
Relative Strength Index (RSI) 63.96 70.84
Support Level $0.89 $0.36
Resistance Level $3.75 N/A
Average True Range (ATR) 0.25 0.91
MACD -0.01 0.89
Stochastic Oscillator 60.40 66.49

Price Performance

Historical Comparison
OMH
GTBP

About OMH Ohmyhome Limited

Ohmyhome Ltd is a data and technology-driven property technology company based in Singapore. Through its subsidiaries, it operates a one-stop-shop property platform that provides end-to-end property solutions and services for its customers, which comprises brokerage services and emerging and other services, such as home renovation and furnishing services, listing and research, mortgage referral, legal services, and insurance referral services. The company derives its revenues from two sources: revenue from brokerage services, property management services, Digital Marketing Services, and emerging and other services. The firm operates in two segments, which are Brokerage, emerging and another related service; and Estate management services and other related services in Singapore.

About GTBP GT Biopharma Inc.

GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. The company is engaged in discovering, developing, and commercializing therapeutics from its proprietary product platform across various disease areas, mainly focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platform offers immuno-oncology products designed to treat hematologic malignancies, sarcoma, and solid tumors.

Share on Social Networks: